Purpose: Our study aimed to investigate the functional connectivity (FC) between the hippocampus and other brain regions in epilepsy patients with depressive symptoms. Methods: Epilepsy patients with and without depressive symptoms, assessed using the 17-item Hamilton Depression Rating Scale scores, were enrolled. Healthy volunteers were recruited as the control group. Resting state functional magnetic resonance imaging was performed, and the data were processed using Resting-State fMRI (DPARSFA2.0) software. The regional homogeneity (ReHo) values and the FC between the right hippocampus and other brain regions were analysed. Results: The ReHo value of the cerebellum (particularly the left cerebellar hemisphere) was significantly lower in epilepsy patients than in healthy controls, and was lower in epilepsy patients with depressive symptoms (EP + DS group) than in those without depressive symptoms (EP-DS group, p < 0.05). Additionally, the FC between the right hippocampus and the bilateral cerebellum was significantly greater in the EP + DS group than in the EP-DS group (p < 0.05). Moreover, abnormal ReHo values in the bilateral frontal lobes, including the right anterior cingulate cortex, and changes in the FC between the right hippocampus and the bilateral frontal lobes were found in the EP + DS group. Minor changes in the FC between the temporal and parietal lobes were also found in the epilepsy patients. Conclusion: The functional right hippocampus-cerebellum circuit might contribute to the pathogenesis of depressive symptoms in epilepsy, with the exception of brain areas associated with emotion such as the frontal and temporal lobes. Modulating the hippocampus-cerebellum circuit is a potential therapeutic strategy for epilepsy patients with depressive symptoms.
Introduction
Depression is highly common in patients with epilepsy, with a prevalence of approximately 30% in patients with recurrent seizures [1] . Depression not only negatively affects patient quality of life but is also correlated with cognitive functioning in patients with epilepsy [2, 3] . However, the mechanisms underlying the comorbidity of epilepsy and depression remain unclear. Evidence from clinical and laboratory research indicates that there are common pathogenic mechanisms associated with epilepsy and depression [4] .
The hippocampus is an important brain region involved in emotional processing and likely contributes to the comorbidity of epilepsy and depression, as both of these conditions are associated with reduced hippocampal volumes [5, 6] . Shamim et al. found that contralateral hippocampal atrophy is correlated with depression in patients with temporal lobe epilepsy (TLE) [7] . A single proton magnetic resonance spectroscopy ( 1 H-MRS) study by Gilliam et al. reported that the severity of depressive symptoms was positively correlated with the abnormality of the creatine/N-acetylaspartate ratio in the hippocampus of patients with TLE, indicating that depression is associated with hippocampal dysfunction [8] . Two positron emission tomography (PET) imaging studies by Savic et al. and Hasler et al. demonstrated that patients with comorbid TLE and depression exhibited a significantly more pronounced reduction in 5-HT 1A receptor binding in the hippocampus than did those without depression [9, 10] . Our previous 1 H-MRS study also indicated that an increased glutamate and glutamine/creatine (Glx/Cr) ratio in the right hippocampus is an independent risk factor for depressive symptoms in patients with epilepsy [11] . These pieces of evidence indicate that the hippocampus is an essential area that not only mediates epileptic discharges but also regulates emotion. The changes in the functional connectivity (FC) between the hippocampus and other specific brain regions in patients with comorbid epilepsy and depression remain to be investigated.
Resting state functional magnetic resonance imaging (fMRI) can detect regional neuronal activity alterations and FC between different areas of the brain, and has been widely used to study the mechanisms underlying neurological and psychiatric diseases [12, 13] . Regional homogeneity (ReHo) analysis evaluates the degree of synchronization between the time-series of a voxel and its neighbouring voxels, and the ReHo value represents the local neuronal activity [14] . In this study, we employed the resting state fMRI technique to observe the ReHo values in different brain regions and the FC between the hippocampus and other brain regions in epilepsy patients with and without depressive symptoms.
As many factors, such as antiepileptic drugs (AEDs), may affect functional networks in the brain, previous studies predominantly recruited patients with TLE who had not been prescribed AEDs [15, 16] . However, in the real world, > 90% of patients with epilepsy are prescribed AEDs as a first line treatment for an extended period. In such patients, changes in brain functional networks may occur owing to the complicated combined effects of epilepsy, comorbidities, and AEDs. Therefore, in this study, we enrolled a group of epilepsy patients with depressive symptoms, a group of epilepsy patients without depressive symptoms, and a group of healthy volunteers (control group). We examined the ReHo values in different brain regions and the FC between the right hippocampus and other brain regions in the three groups.
Methods

Participants
Patients with epilepsy who met the following criteria were included as the group of patients with comorbid epilepsy and depressive symptoms (EP + DS group) in our study: 1) are 18-50 years old, no gender limitation; 2) have experienced epilepsy for ≥6 months; 3) have a score of ≥7 on the 17-item Hamilton Depression Rating Scale (HAMD-17); 4) have not been under treatment with any medication other than AEDs in the past 2 weeks; and 5) have no abnormal findings on magnetic resonance imaging (MRI) with T1, T2, and fluid-attenuated inversion recovery (FLAIR) sequences. The exclusion criteria were as follows: 1) a history of psychiatric diseases or psychiatric symptoms as evaluated by the Brief Psychiatric Rating Scale (BPRS); 2) a score of < 24 on the Mini-Mental State Examination (MMSE); and 3) severe organ failure and malignant tumours. The epilepsy patients without depressive symptoms (EP-DS group) were recruited based on the above inclusion and exclusion criteria, but the HAMD-17 score cut-off was < 7. Age-, gender-, and education-matched healthy volunteers were recruited as the healthy control (HC) group.
Basic demographic data including age, gender, marital state, and education level were collected from all participants. The seizure-related parameters such as seizure type, frequency, severity, aetiology, history of status epilepticus (SE), and AED use in the patients with epilepsy were recorded by a neurologist. All participants were fully informed of the aim of this study and provided written informed consent. The local ethics committee approved this study.
Neuropsychological evaluation
All participants were assessed with the HAMD-17 to evaluate the presence and severity of depressive symptoms. The Chinese version of the HAMD-17 has been proven to have good reliability, and a HAMD-17 score of ≥7 is considered to indicate depressive symptoms based on the generally acknowledged standard [17, 18] . The MMSE and BPRS were used to exclude patients with cognitive disorders or psychiatric symptoms that might be confused with depressive symptoms. Participants with a MMSE score of ≤24 or a BPRS score of > 35 were excluded [19] . The Chinese versions of the MMSE and BPRS have both been tested for reliability [20, 21] .
3. fMRI data acquisition and processing 3.1. Image acquisition fMRI was performed using a 3.0-T clinical scanner with an eightchannel phased array head coil (SignaHDx, GE Medical System, Milwaukee, WI, USA). The participants were provided with a pair of earplugs to reduce noise disturbance. They were instructed to lie still in the GE quadrature radiofrequency head coil with foam cushioning for motion stability, keep their eyes closed, and remain calm during scanning. After verifying patient position, image quality, and voxel positioning, high-resolution T1-weighted images were acquired using a 3D magnetic prepared rapid gradient echo pulse sequence, with slice thickness = 1 mm, echo time (TE) = 12 ms, repetition time (TR) = 500 ms, field of view (FOV) = 256 × 256 mm, matrix size = 256 × 256 mm, 192 slices in the axial plane, voxel size = 1 × 1 × 1 mm. The resting state fMRI scans of the whole brain were acquired using a T2*-weighted echo-planar imaging sequence: TR = 2000 ms, TE = 30 ms, number of excitations (NEX) = 1, matrix size = 128 × 128, FOV = 256 × 256 mm, flip angle = 90. Further T2-weighted (TR = 4500 ms, TE = 99 ms, NEX = 1) and FLAIR (TR = 10,002 ms, TE = 133 ms, inversion time = 2200 ms, NEX = 1) images were acquired to screen for incidental neuroradiological abnormalities.
fMRI data processing
In this study, the Data Processing Assistant for Resting-State fMRI 2.0 (DPARSFA2.0, http://restfmri.net/forum/) developed by the State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University was used to process the resting state fMRI data [21] . As described previously [22] , DICOM images were converted into the NIFTI format. To maintain the magnetization equilibrium, the images from the first ten time points were removed. Slice timing correction and realignment were performed. Excessive motion was defined as parallel movement in any direction of > 2.5 mm or rotation of > 2.5°. The functional images were then spatially normalised to the Montreal Neurological Institute space and the resampled voxel size was 3 × 3 × 3 mm. The images were then subjected to detrending and filtering (0.01 Hz < f < 0.08 Hz) to reduce low-frequency drift and filter high-frequency physiological noise. Finally, a multiple linear regression analysis was performed to remove covariates.
ReHo analysis
A software package "Resting-State fMRI Data Analysis Toolkit" (REST, http://restfmri.net) was used to analyse the ReHo values. The principle is to obtain voxel-wise measurement of the similarity of the time series at a given voxel to the time series of its 26 nearest neighbours according the following formula:
Each ReHo map was divided by its own mean ReHo value of the entire brain for standardization. A Gaussian filter of 4 mm full width was used to smooth the standardised ReHo map. Finally, a two-tailed, two-sample t test was performed to determine the pairwise differences in the ReHo values between the EP + DS, EP-DS, and HC groups. A corrected threshold of p < 0.05 was used and the minimum cluster size was set at 12 voxels. The detailed procedures were previously described by Yin et al. [22] .
FC analysis
The right hippocampus served as the seed region of interest (ROI) based on the Automated Anatomical Labelling template [15] . Patients with hippocampal abnormalities were excluded. The correlation between the reference time course and time series of other voxels in the brain was calculated using Pearson's correlation coefficient analysis. In order to keep the resulting correlation coefficients distributed approximately normally, these data were transformed into z-scores using Fisher's r-to z-transformation. The FC in the right hippocampus was compared among the EP + DS, EP-DS, and HC groups. An independent sample t test was used for intergroup comparisons. The corrected thresholds were set at p < 0.05 and the cluster size was > 12 voxels.
Statistical analysis
IBM SPSS version 21.0 (IBM Inc., Armonk, NY, USA) software was used to perform the statistical analysis of patients' demographic and seizure-related data. Quantitative variables are presented as mean ± standard deviation (SD). When the data fit a normal distribution, an independent t-test or one-way ANOVA was used to compare the means between groups. A nonparametric test was used in other instances. Categorical variables such as gender differences and seizure types were analysed using the chi-square test. A p-value of < 0.05 was considered significant.
Results
Clinical profiles of the participants
A total of 47 participants were enrolled. Fifteen epilepsy patients with depressive symptoms were recruited in the EP + DS group, the 17 matched epilepsy patients without depressive symptoms were set as the EP-DS group, and the 15 matched healthy volunteers without depressive symptoms were included in the HC group. Seizures were classified based on the International League Against Epilepsy (ILAE) classification (2017). There were 13 patients with generalised tonic-clonic seizures (GTCS), 9 with focal seizures (FS), and 10 with focal to bilateral tonic-clonic seizures (FS to GTCS) in this study. All patients with FS and FS to GTCS had TLE. The demographic data and clinical characteristics of the participants are listed in Table 1 . Comparisons of these parameters indicated no differences in age, gender, years of education, age of epilepsy onset, epilepsy duration, seizure types, seizure frequency, AED use, National Hospital Seizure Severity Scale (NHS3) scores, and MMSE scores among the EP + DS, EP-DS, and HC groups (see Table 1 ).
The ReHo value in the cerebellum significantly decreased and the FC between the right hippocampus and bilateral cerebellum increased in the EP + DS group compared to the EP-DS and HC groups
The ReHo values were compared among the EP + DS, EP-DS, and HC groups. The results indicated that the ReHo value in the left cerebellum was significantly lower in the EP + DS and EP-DS groups than in the HC group, and was lower in the EP + DS group than in the EP-DS group (p < 0.05). The ReHo value in the right cerebellum was also markedly lower in the EP + DS group than in the HC group (p < 0.05).
However, interestingly, the FC values between the right hippocampus and the bilateral cerebellum including the anterior and posterior cerebellum lobes were significantly greater in the EP + DS group than in the EP-DS and HC groups (p < 0.05) (see Table 2 , Fig. 1 and 2 ).
Changes in the ReHo values in the cerebral regions among the EP + DS, EP-DS, and HC groups
In addition to the above findings, the ReHo values in the EP + DS group were greater than those in the EP-DS group mainly in the right anterior cingulate cortex (ACC) and the bilateral frontal lobes (including the right sub-gyrus of the frontal lobe, right inferior frontal lobe, left middle frontal lobe, and left superior frontal lobe) (p < 0.05). In addition, the ReHo values in the EP + DS group were lower than those in the HC group in the left inferior gyrus, right sub-gyrus, and inferior gyrus of the temporal lobe; the left superior gyrus of the frontal lobe; and the left precuneus of the parietal lobe. The ReHo values in the EP-DS group were lower than those in the HC group in the left ACC and the right inferior occipital lobe, while the ReHo values in the EP-DS group were greater than those in the HC group in the brainstem, the bilateral temporal lobes (including the left superior, middle, inferior temporal lobe and the right superior and middle temporal lobe), and the bilateral parietal lobes (including the bilateral post-central gyrus and the left superior parietal lobe) (see Table 3 ).
Changes in the FC between the right hippocampus and other cerebral regions among the EP + DS, EP-DS, and HC groups
Changes in the FC between the right hippocampus and other cerebral regions were also analysed. The FC was significantly greater in the EP + DS group than in the EP-DS group and primarily involved the left inferior temporal lobe, the bilateral frontal lobes, and the right inferior parietal lobe (p < 0.05). In contrast, the FC values in the left superior temporal lobe and the right post-central gyrus were significantly lower in the EP + DS group than in the EP-DS group (p < 0.05). In addition, the abnormal changes in the FC in the bilateral temporal, frontal, and parietal lobes in patients with epilepsy compared to the HC group were as follows: the FC in the right middle and inferior temporal lobe was greater in the EP + DS group than in the HC group; the FC in the bilateral temporal lobes (including the right sub-gyrus of the temporal lobe, and the right parahippocampus, right superior temporal lobe, and left middle temporal lobe), bilateral precuneus of the parietal lobe, and right precentral and postcentral gyri was significantly greater in the EP-DS group than in the HC group; and the FC in the bilateral frontal lobes and the right parietal lobe was lower in the EP-DS group than in the HC group (see Table 4 ).
Discussion
In this study, we used the ReHo value and FC measured by restingstate fMRI to analyse the differences in regional changes and FC between the right hippocampus and other brain regions in epilepsy patients with and without depressive symptoms. We used the right hippocampus as the seed ROI because the hippocampus is an essential area involved in the comorbidity of epilepsy and depression, the right brain is more involved in emotion regulation, and our previous 1 H-MRS study demonstrated that the Glx/Cr ratio in the right hippocampus is an independent risk factor for depressive symptoms in patients with epilepsy [11] . The cerebellum is generally regarded as a region involved in regulating balance and motor control. However, Schmahmann et al. proposed that the cerebellum has additional non-motor functions [23] . The cerebellum plays an important role in the epileptogenic network. An animal study found that decreased activity of deep cerebellar nuclei, particularly the dentate nucleus and fastigial nucleus, was related to epileptogenesis [24] . As the cerebellum has a prominent ascending input to the thalamus, stimulation of the centrally located cerebellar nuclei can halt generalised seizures in experimental epilepsy models [25] . In our study, the decreased ReHo value in the cerebellum in patients with epilepsy illustrated that the decreased activity of cerebellar neurons might be involved in the epileptogenic network, which was in accordance with the above studies.
Additionally, the cerebellum plays a key role in emotional processing. Brambilla et al. and Yucel et al. found structural abnormalities in the cerebella of patients with major depressive disorder (MDD), such as a smaller cerebellum or cerebellar vermis compared to those of HCs [26, 27] . Functional changes, for example, a significantly decreased ReHo value in the cerebellum, were observed in depression patients [28] , and abnormal cerebellar connectivity with the ACC or frontal lobes was also observed in patients with severe depression and those who were resistant to treatment [29, 30] . Moreover, the studies by Rochefort et al. and Yu et al. indicated the presence of direct connections between the cerebellum and the hippocampus via the midline or the fastigial nucleus of the cerebellum [31, 32] . Abnormal FC between the cerebellum and the hippocampus has also been observed in patients with depression [33] . A study by Krook-Magnuson et al. demonstrated that a cerebellar-directed optogenetic intervention inhibited spontaneous hippocampal seizures in a mouse model of TLE, indicating that modulating the connectivity between the cerebellum and the hippocampus elicits an anticonvulsive effect [34] . The results of the present study are consistent with these previous studies, suggesting that decreased activity of cerebellar neurons and abnormal FC between the right hippocampus and the cerebellum might contribute to depressive symptoms in epilepsy.
The ACC and frontal lobes are vital brain regions involved in emotion regulation. A study using diffusion tensor imaging found that the white matter connecting the ACC and midline motor regions with the prefrontal cortex was significantly decreased in patients with MDD [35] . Functional changes measured by task-based and resting state fMRI indicated that the activity of the right ACC, posterior cingulate, and medial frontal gyrus was significantly increased in patients with bipolar The ReHo value in the cerebellum (particularly the left cerebellar hemisphere) was significantly decreased and the FC between the right hippocampus and the cerebellum was significantly increased in the EP + DS group compared to the EP-DS and HC groups, p < 0.05. disorder and MDD [36] . Studies using PET also demonstrated that the metabolism in the cingulate gyrus and the regional cerebral blood flow in the paralimbic area and the prefrontal cortex were significantly increased in patients with MDD [37, 38] . Antidepressant drugs targeting the ventromedial prefrontal cortex can reverse depression, indicating that the projection from the ventromedial prefrontal cortex to the limbic nucleus accumbens is an essential pathway in depression [39] . In patients with TLE, Kemmotsu et al. found that the severity of depressive symptoms was associated with stronger FC between the hippocampus and the prefrontal cortex [15] . Another study demonstrated higher activity in the right ACC in treatment-naïve TLE patients with depressive symptoms than in HCs and TLE patients without depressive symptoms [16] . The results of the present study also indicate the presence of extensive abnormal FC between the right hippocampus and bilateral frontal lobes (including the superior, middle, and inferior areas) in epilepsy patients with depressive symptoms. Furthermore, another finding in our study was abnormal FC in the temporal and parietal regions in patients with epilepsy. We speculate that patients with epilepsy may occasionally experience psychomotor disturbances such as decreased executive function, which might explain Fig. 1. Top) The FC between the right hippocampus and the bilateral cerebellum was significantly greater in the epilepsy patients with depressive symptoms (EP + DS group) than in those without depressive symptoms (EP-DS group) (p < 0.05); Bottom) the ReHo value in the left cerebellum was significantly lower in the EP + DS group than in the EP-DS group (p < 0.05). FC, functional connectivity. Fig. 2 . Top) The FC between the right hippocampus and the bilateral cerebellum was significantly greater in the epilepsy patients with depressive symptoms (EP + DS group) than in the healthy controls (HC group) (p < 0.05); Bottom) The ReHo value in the bilateral cerebellum was significantly lower in the EP + DS group than in the HC group (p < 0.05). FC, functional connectivity. the extensive abnormal neural circuits in our real-world study.
This study has some limitations. We focused our study on depressive symptoms and did not exclude anxiety by using other anxiety scales; however, we used the MMSE and BPRS to exclude patients with cognitive disorders or psychiatric symptoms that might be confused with depressive symptoms. The patients with epilepsy had all been prescribed AEDs, but there was no difference in the types of AEDs between the EP + DS and EP-DS groups. Since many types of AEDs carry the risk of promoting depressive symptoms, the presence of AED-induced functional changes in some brain regions may need further research [40] . Another limitation of our study is that we did not stratify the epilepsy patients according to their seizure types, due to the small sample size. However, we attempted to maintain continuity in the seizure types between the EP + DS and EP-DS groups.
In conclusion, our study demonstrates that, aside from common brain areas associated with emotion, such as the frontal and temporal lobes, epilepsy patients with depressive symptoms as evaluated by the HAMD-17 also have abnormal ReHo values in the cerebellum and abnormal FC between the right hippocampus and bilateral cerebellum compared to those without depressive symptoms and healthy persons. These findings indicate that the functional changes in the right hippocampal-cerebellar circuit and certain other brain regions associated with emotion might contribute to the depressive symptoms in patients with epilepsy in the real world. Thus, modulating the hippocampal-cerebellar circuit might be a promising therapeutic target for treating epilepsy patients with depressive symptoms in the future.
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